Euvitro

Euvitro is a Spain-based reproductive medicine company operating under the Eugin brand and focused on assisted reproduction and fertility care. The business provides commercial clinical services including IVF, egg donation, fertility preservation, and related reproductive health services rather than a traditional biopharma drug pipeline. Historically part of Eugin Group, the company was sold by Fresenius to a consortium led by IVI RMA and GED Capital in a transaction announced in November 2023 for up to \u20ac500 million including earn-outs. Euvitro appears to be the legal operating entity behind Eugin clinics in Barcelona and related fertility activities, with a strong emphasis on international patients, clinical research, and reproductive medicine expertise.